We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.21B
AUM Growth
+$86.2M
Cap. Flow
+$17.4M
Cap. Flow %
1.44%
Top 10 Hldgs %
29.62%
Holding
209
New
10
Increased
131
Reduced
56
Closed
6

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$16.4M
2
WM icon
Waste Management
WM
+$12.8M
3
SLB icon
SLB Ltd
SLB
+$8.41M
4
AAPL icon
Apple
AAPL
+$1.75M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.35M

Sector Composition

Rank Sector Weight
1 Healthcare 15.5%
2 Consumer Staples 12.56%
3 Technology 11.92%
4 Financials 7.47%
5 Energy 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
26
Novo Nordisk
NVO
$209B
$17.3M 1.43%
598,370
+33,800
+6% +$936K
HRL icon
27
Hormel Foods
HRL
$13.8B
$15.9M 1.32%
352,557
-600
-0.2% -$25.8K
RDS.A
28
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$15.8M 1.3%
267,211
+23,754
+10% +$1.39M
USB icon
29
US Bancorp
USB
$99.6B
$15.5M 1.29%
262,167
-43
-0% -$2.49K
CERN
30
DELISTED
Cerner Corp
CERN
$15.5M 1.28%
211,019
+759
+0.4% +$52.5K
PEG icon
31
Public Service Enterprise Group
PEG
$37.7B
$15.2M 1.26%
257,837
-1,913
-0.7% -$116K
REGN icon
32
Regeneron Pharmaceuticals
REGN
$80.8B
$14.3M 1.18%
37,956
+1,835
+5% +$617K
XEL icon
33
Xcel Energy
XEL
$48.8B
$14M 1.16%
220,559
+12,008
+6% +$751K
D icon
34
Dominion Energy
D
$59.3B
$13.8M 1.14%
166,749
+12,137
+8% +$992K
BIL icon
35
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$13M 1.08%
142,673
-4,134
-3% -$378K
LMT icon
36
Lockheed Martin
LMT
$136B
$13M 1.07%
33,349
+1,524
+5% +$585K
PM icon
37
Philip Morris
PM
$295B
$12.7M 1.05%
149,786
+16,961
+13% +$1.4M
AMGN icon
38
Amgen
AMGN
$222B
$12.7M 1.05%
52,735
+3,795
+8% +$837K
CHRW icon
39
C.H. Robinson
CHRW
$17.5B
$12.7M 1.05%
161,846
-672
-0.4% -$53.5K
VFC icon
40
VF Corp
VFC
$5.89B
$12.5M 1.04%
125,800
-3,064
-2% -$275K
CTSH icon
41
Cognizant
CTSH
$26B
$12.1M 1%
195,054
+1,671
+0.9% +$103K
WBA
42
DELISTED
Walgreens Boots Alliance
WBA
$11.9M 0.98%
+201,216
New +$11.6M
PNW icon
43
Pinnacle West Capital
PNW
$12.2B
$11.8M 0.98%
131,293
+9,296
+8% +$839K
GILD icon
44
Gilead Sciences
GILD
$165B
$11.7M 0.97%
180,595
-2,566
-1% -$167K
CAH icon
45
Cardinal Health
CAH
$55.4B
$11.5M 0.95%
226,531
+14,595
+7% +$754K
MCD icon
46
McDonald's
MCD
$195B
$11.4M 0.94%
57,447
+66
+0.1% +$13.1K
NVS icon
47
Novartis
NVS
$297B
$11.2M 0.92%
117,852
+7,090
+6% +$636K
MMM icon
48
3M
MMM
$94.3B
$11.1M 0.92%
75,208
+820
+1% +$115K
MO icon
49
Altria Group
MO
$114B
$11.1M 0.91%
221,677
+11,833
+6% +$558K
QUAL icon
50
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$10.9M 0.91%
108,401
+35,529
+49% +$3.42M

Similar funds

GW Henssler & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, GW Henssler & Associates held 209 positions worth $1.21B, up 7.7% from $1.12B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

GW Henssler & Associates's Q4 2019 filing shows 10 new, 131 increased, 56 reduced and 6 closed positions. Its largest new stake was Walgreens Boots Alliance: 201,216 shares worth $11.9M. The largest sale was Ecolab, an estimated $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Technology.

  • GW Henssler & Associates's largest Q4 2019 buy was Walgreens Boots Alliance: 201,216 shares worth $11.9M.
  • GW Henssler & Associates added most to Chevron in Q4 2019, an estimated $9.06M increase.
  • GW Henssler & Associates's biggest Q4 2019 reduction was Ecolab, cutting an estimated $16.4M.
  • GW Henssler & Associates fully exited SLB Ltd in Q4 2019, selling an estimated $8.41M.
  • GW Henssler & Associates's ten largest holdings make up 30% of its $1.21B portfolio in Q4 2019.
  • GW Henssler & Associates opened 10 new positions and closed 6 in Q4 2019.
  • GW Henssler & Associates's portfolio value rose 7.7% quarter-over-quarter to $1.21B.

Based on GW Henssler & Associates's 13F filing for Q4 2019, filed 24 Feb 2020.